Hamanoue, Satoshi
Suwabe, Tatsuya http://orcid.org/0000-0003-0825-2512
Ubara, Yoshifumi
Kikuchi, Koichi
Hazue, Ryo
Mise, Koki
Ueno, Toshiharu
Takaichi, Kenmei
Matsumoto, Kana
Morita, Kunihiko
Funding for this research was provided by:
Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labour and Welfare of Japan
Okinaka Memorial Institute for Medical Research, Toranomon Hospital
Article History
Received: 28 May 2018
Accepted: 4 October 2018
First Online: 19 October 2018
Ethics approval and consent to participate
: This prospective observational study was reviewed and approved by the ethics committee of Toranomon Hospital in July 2013. This study was registered with the University Hospital Medical Information Network (UMIN) as “Penetration of meropenem into cysts in patients with autosomal dominant polycystic kidney disease (ADPKD)”, UMIN ID 000011292. All patients fitting gave written consent after being fully informed about this study. The study protocol conformed to the provisions of the Declaration of Helsinki.
: Written consent to publish clinical information at the onset of cyst infection was obtained from study participants. Written consent forms are stored in Department of Nephrology, Toranomon Hospital and can be requested at any time.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.